Vaccine for dementia to enter human trials after successful tests on mice

Vaccine for dementia to enter human trials after successful tests on mice - The Mandatory Training Group UK -

Vaccine for dementia to enter human trials after successful tests on mice

Vaccine for dementia to enter human trials after successful tests on mice.

‘This could be revolutionary,’ says lead researcher as treatment found to remove causes of brain decline.

Vaccine for dementia to enter human trials after successful tests on mice - The Mandatory Training Group UK -

Stock image (iStock)

A vaccine designed to prevent dementia is to enter human trials after successful tests on mice.

If the treatment is proven to work safely on people, it could be available within a decade, researchers say.

The revelation, published in the journal Alzheimer’s Research & Therapy, comes after 20 years of research backed by the US government and largely carried out in Australia.

The treatment – a combination of two different drugs – is said to work by targeting and then removing the brain plaque and nanofibre tangles which lead to cognitive decline and memory failure.

It also has the potential to prevent Alzheimer’s in people who are predisposed to the disease, researchers say.

It is said to be unlike anything currently available because most medicines have achieved so far is to reduce symptoms rather than targeting the specific problems affecting the brain.

Professor Nikolai Petrovsky, a specialist in endocrinology at Flinders University in Adelaide, where much of the work is being carried out, said: “This vaccine could be revolutionary. It’s not something that will be available tomorrow, but it’s an exciting step in the right direction.”

He told Australia’s Daily Telegraph: “This is not the start of the journey, it’s the end.”

And he added he was now optimistic human trials will have started within 20 months.

However, there may be a reason for caution, as several promising drugs said to help with dementia have previously failed clinical trials.

Creative Commons Disclosure

This news story was published by The IndependentClick here to see the original news article.

About the Mandatory Training Group

The Mandatory Training Group is the leading UK provider of accredited healthcare and social care statutory and mandatory training courses, programs and qualifications.

Click on the links below to find out more information on our dementia awareness and mental health training courses and programs.

Contact our Support Team on 02476100090 or via Email for more courses relating to the Care Quality Commission (CQC) and other regulatory compliance requirements.

Vaccine for dementia to enter human trials after successful tests on mice.

Share this post

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.


%d bloggers like this: